Pasithea Therapeutics Stock Price, News & Analysis
Company Description
Welcome to the overview page for Pasithea Therapeutics (ktta), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Oppenheimer virtual presentation
Cohort 4-8 longer-term follow-up
PAS-004 data presentation
Short Interest History
Short interest in Pasithea Therapeutics (ktta) currently stands at 559.6 thousand shares, up 23.8% from the previous reporting period, representing 17.1% of the float. Over the past 12 months, short interest has increased by 6327.3%. This moderate level of short interest indicates notable bearish positioning.
Days to Cover History
Days to cover for Pasithea Therapeutics (ktta) currently stands at 1.4 days, up 39% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 39% over the past year, indicating either rising short interest or declining trading volume.